Page last updated: 2024-12-06

1,2-dipalmitoyl-3-phosphatidylethanolamine

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

You seem to be asking about **1,2-dipalmitoyl-sn-glycero-3-phosphoethanolamine (DPPE)**, not 1,2-dipalmitoyl-3-phosphatidylethanolamine.

**1,2-Dipalmitoyl-sn-glycero-3-phosphoethanolamine (DPPE)** is a type of **phospholipid**, a key component of cell membranes. Here's a breakdown of its structure and importance in research:

**Structure:**

* **Dipalmitoyl:** This refers to two palmitic acid molecules, which are saturated fatty acids, attached to the glycerol backbone at positions 1 and 2.
* **sn-glycero-3-phosphoethanolamine:** This refers to the glycerol backbone with a phosphate group attached at position 3 and an ethanolamine molecule attached to the phosphate group.

**Importance in Research:**

DPPE is valuable in research for several reasons:

* **Model membrane studies:** It's a common component of model membranes, such as liposomes and lipid bilayers. These models are used to study membrane properties, protein interactions, and drug delivery mechanisms.
* **Lipid bilayer studies:** DPPE helps researchers understand the physical properties of lipid bilayers, including fluidity, permeability, and phase transitions.
* **Drug delivery:** DPPE is incorporated into liposomes and other drug delivery systems, enhancing their stability and targeting capabilities.
* **Biocompatibility:** DPPE is biocompatible, meaning it is well-tolerated by the body, making it suitable for drug delivery and other biomedical applications.
* **Cell signaling:** DPPE is involved in various cellular processes, including cell signaling and membrane trafficking. Research on DPPE can shed light on these processes.
* **Studies on lipid disorders:** DPPE plays a role in some lipid disorders, making it a potential target for therapeutic development.

**Overall:** DPPE is an important phospholipid with a variety of applications in research, from basic membrane studies to the development of novel drug delivery systems.

1,2-dipalmitoyl-3-phosphatidylethanolamine: RN given refers to parent cpd without isomeric designation [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID65109
SCHEMBL ID2733807
MeSH IDM0050766

Synonyms (59)

Synonym
palmitin, 1,2-di-, phosphate, 2-aminoethyl ester, dl- (6ci)
1,2-dipalmitoyl-3-dl-glycerylphosphorylethanolamine
dl-a-cephalin dipalmitate
1,2-dipalmitoyl-rac-glycerophosphoethanolamine
ethanol, 2-amino-, dihydrogen phosphate (ester), monoester with 1,2-dipalmitin, dl- (8ci)
1,2-dihexadecanoyl-rac-glycero-3-phosphoethanolamine
dl-dipalmitoylphosphatidylethanolamine
1,2-dipalmitoyl-dl-3-glycerophosphatidylethanolamine
dl-b,g-dipalmitoyl-a-cephalin
a-cephalin, b,g-dipalmitoyl
(+-)-1-[[[(2-aminoethoxy)hydroxyphosphinoyl]oxy]methyl]ethane-1,2-diyl bishexadecanoate
1,2-dipalmitoylphosphatidylethanolamine
palmitin, 1,2-di-, 2-aminoethyl hydrogen phosphate, dl- (8ci)
dipalmitoyl cephalin
1,2-dipalmitoyl-dl-phosphatidylethanolamine
hexadecanoic acid, 1-[[[(2-aminoethoxy)hydroxyphosphinyl]oxy]methyl]-1,2-ethanediyl ester, (+/-)-
dl-a-dipalmitoylphosphatidylethanolamine
1,2-dipalmitoyl glycerylphosphorylethanolamine
b,g-dipalmitoyl-dl-a-cephalin
5681-36-7
rac-phosphatidylethanolamine, 1,2-dipalmitoyl
1,2-dipalmitoyl-rac-glycero-3-phosphoethanolamine, synthetic, >=98%
1,2-dipalmitoyl-3-phosphatidylethanolamine
D-6049
1,2-dipalmitoyl-rac-glycero-3-phosphoethanolamine
D-6061
[(2r)-3-[2-aminoethoxy(hydroxy)phosphoryl]oxy-2-hexadecanoyloxypropyl] hexadecanoate
unii-hya85h5s0g
hya85h5s0g ,
einecs 227-142-8
1,2-dipalmitoylcephaline
(1)-1-((((2-aminoethoxy)hydroxyphosphinoyl)oxy)methyl)ethane-1,2-diyl bishexadecanoate
hexadecanoic acid, 1-((((2-aminoethoxy)hydroxyphosphinyl)oxy)methyl)-1,2-ethanediyl ester, (+-)-
l-|a,|a-dipalmitoyl-|a-cephalin
FT-0625216
.beta.,.gamma.-dipalmitoyl-dl-.alpha.-cephalin
dl-.alpha.-dipalmitoylphosphatidylethanolamine
rac-1,2-dipalmitoylglycero-3-phosphoethanolamine
dppe, dl-
dl-.alpha.-cephalin dipalmitate
SCHEMBL2733807
dipalmityl phosphatidylethanolamine
palmitin, 1,2-di-, 2-aminoethyl hydrogen phosphate
hexadecanoic acid, 1-[[[(2-aminoethoxy)hydroxyphosphinyl]oxy]methyl]-1,2-ethanediyl ester
2-([(2-aminoethoxy)(hydroxy)phosphoryl]oxy)-1-[(palmitoyloxy)methyl]ethyl palmitate #
SLKDGVPOSSLUAI-UHFFFAOYSA-N
hexadecanoic acid, 1-[[[hydroxy(2-aminoethoxy)phosphinyl]oxy]methyl]-1,2-ethanediyl ester
mfcd00036776
dipalmitoyl-phosphoethanolamine
dppe;l-beta,gamma-dipalmitoyl-alpha-cephalin
DTXSID301016031
dipalmitoyl phosphatidylethanolamine;1,2-dihexadecanoyl-sn-glycero-3-phosphoethanolamine
BCP34415
Q27280160
STARBLD0009765
PD043169
SY057796
3-[[(2-aminoethoxy)(hydroxy)phosphoryl]oxy]propane-1,2-diyl (2r)-dipalmitate
pe 16:0_16:0

Research Excerpts

Pharmacokinetics

ExcerptReferenceRelevance
"Physiologically based pharmacokinetic (PBPK) models were developed for design and optimization of liposome therapy for treatment of overdoses of tricyclic antidepressants and local anesthetics."( A physiologically based pharmacokinetic (PBPK) model for predicting the efficacy of drug overdose treatment with liposomes in man.
Chauhan, A; Howell, BA, 2010
)
0.36
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (362)

TimeframeStudies, This Drug (%)All Drugs %
pre-199063 (17.40)18.7374
1990's106 (29.28)18.2507
2000's113 (31.22)29.6817
2010's77 (21.27)24.3611
2020's3 (0.83)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 8.65

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index8.65 (24.57)
Research Supply Index5.92 (2.92)
Research Growth Index4.56 (4.65)
Search Engine Demand Index0.00 (26.88)
Search Engine Supply Index0.00 (0.95)

This Compound (8.65)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials1 (0.27%)5.53%
Reviews3 (0.81%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other366 (98.92%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]